C4 Therapeutics grants new hire stock options for 85,480 shares under Nasdaq rule
PUBT · 05/18 20:01
Share
Listen to the news
- C4 Therapeutics set an inducement equity award for a new hire, granting non-qualified stock options for 85,480 common shares on May 18, 2026.
- The options carry an exercise price equal to the stock’s closing price on the grant date.
- Vesting runs over four years, with 25% vesting on the first anniversary of the employee’s start date.
- The remaining shares vest in 36 equal monthly installments, contingent on continued employment through each vesting date.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. C4 Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202605181601PRIMZONEFULLFEED9722170) on May 18, 2026, and is solely responsible for the information contained therein.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.
Copyright © 2026 Webull. All Rights Reserved